Light therapy shows promise against tough lung cancer
NCT ID NCT02153229
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether adding a light-activated drug (photodynamic therapy) during surgery can help people with a rare lung cancer called epithelioid malignant pleural mesothelioma live longer. About 52 adults with cancer limited to one side of the chest will receive either standard surgery plus chemotherapy, or the same with an extra light treatment during surgery. The goal is to see if the combination improves survival.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EPITHELIOD MALIGNANT PLEURAL MESOTHELIOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Roswell Park Cancer Institute
Buffalo, New York, 14263, United States
-
University of Pennsylvania
Philadelphia, Pennsylvania, 19104, United States